Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Federal Trade Commission
Cerilliant
QuintilesIMS
Cantor Fitzgerald
Daiichi Sankyo
Colorcon
Express Scripts
Johnson and Johnson

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,658,929

« Back to Dashboard

Summary for Patent: 5,658,929
Title: Sulfonamide fibrinogen receptor antagonists
Abstract:A series of non-peptide derivatives that are antagonists of the fibrinogen IIb/IIIa receptor and thus are platelet anti-aggregation compounds useful in the prevention and treatment of diseases caused by thrombus formation.
Inventor(s): Duggan; Mark E. (Narberth, PA), Egbertson; Melissa S. (Ambler, PA), Halczenko; Wasyl (Hatfield, PA), Hartman; George D. (Lansdale, PA), Laswell; William L. (Perkasie, PA)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:08/505,417
Patent Claim Types:
see list of patent claims
Compound; Composition;

Drugs Protected by US Patent 5,658,929

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 5,658,929

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Japan H09132558 ➤ Sign Up
Denmark 0478363 ➤ Sign Up
European Patent Office 0478363 ➤ Sign Up SPC/GB99/042 United Kingdom ➤ Sign Up
European Patent Office 0478363 ➤ Sign Up C990040 Netherlands ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Queensland Health
Accenture
Johnson and Johnson
Harvard Business School
Chubb
Argus Health
US Army
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.